Mullett Wayne M
Merck Frosst Canada and Co., Kirkland, Quebec, Canada H9H 3L1.
J Biochem Biophys Methods. 2007 Mar 10;70(2):263-73. doi: 10.1016/j.jbbm.2006.10.001. Epub 2006 Oct 10.
The analysis of drugs in various biological fluids is an important criterion for the determination of the physiological performance of a drug. After sampling of the biological fluid, the next step in the analytical process is sample preparation. The complexity of biological fluids adds to the challenge of direct determination of the drug by chromatographic analysis, therefore demanding a sample preparation step that is often time-consuming, tedious, and frequently overlooked. However, direct on-line injection methods offer the advantage of reducing sample preparation steps and enabling effective pre-concentration and clean-up of biological fluids. These procedures can be automated and therefore reduce the requirements for handling potentially infectious biomaterial, improve reproducibility, and minimize sample manipulations and potential contamination. The objective of this review is to present an overview of the existing literature with emphasis on advances in automated sample preparation methods for liquid-chromatographic methods. More specifically, this review concentrates on the use of direct injection techniques, such as restricted-access materials, turbulent-flow chromatography and other automated on-line solid-phase extraction (SPE) procedures. It also includes short overviews of emerging automated extraction-phase technologies, such as molecularly imprinted polymers, in-tube solid-phase micro-extraction, and micro-extraction in a packed syringe for a more selective extraction of analytes from complex samples, providing further improvements in the analysis of biological materials. Lastly, the outlook for these methods and potential new applications for these technologies are briefly discussed.
分析各种生物流体中的药物是确定药物生理性能的一项重要标准。采集生物流体样本后,分析过程的下一步是样本制备。生物流体的复杂性增加了通过色谱分析直接测定药物的难度,因此需要一个往往耗时、繁琐且常被忽视的样本制备步骤。然而,直接在线进样方法具有减少样本制备步骤以及能够对生物流体进行有效预浓缩和净化的优势。这些程序可以自动化,从而减少处理潜在传染性生物材料的需求,提高重现性,并将样本操作和潜在污染降至最低。本综述的目的是概述现有文献,重点是液相色谱法自动样本制备方法的进展。更具体地说,本综述集中于直接进样技术的应用,如受限进样材料、湍流色谱法和其他自动在线固相萃取(SPE)程序。它还简要介绍了新兴的自动萃取相技术,如分子印迹聚合物、管内固相微萃取和填充注射器微萃取,以便从复杂样本中更有选择性地萃取分析物,进一步改进生物材料的分析。最后,简要讨论了这些方法的前景以及这些技术潜在的新应用。